Accuray reported $100K in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 49.7M 10K Sep/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Hologic USD 222.57M 350K Sep/2025
Inogen USD 23K 0 Dec/2023
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Orthofix International USD 39.83M 315K Dec/2025
Surmodics USD 14.3M 13.58M Jun/2025
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Trinity Biotech USD 385.2M 382.82M Jun/2025